Amp M Pharma Peru Sac: D

In 2005, the parent group integrated with , a highly reputable Argentine establishment with nearly eight decades of manufacturing heritage. This partnership catalyzed the formal rollout of the Peruvian branch, allowing D&M Pharma Peru S.A.C. to systematically introduce high-demand specialized medical solutions to Peruvian medical clinics and pharmacies. Key Product Lines and Medical Portfolio

If you are looking for specific, in-depth reports about their financial data or recent imports, they can often be found through professional business intelligence services like EMIS or trade data sources like Veritrade.

A common aerosol inhaler for relief of bronchospasms.

: Aerosol therapies and nebulization solutions are among the company's most recognized products, highlighting:

D&M Pharma focuses on delivering safe and effective medications across several therapeutic areas: d amp m pharma peru sac

Here is a summary of its official registration details:

The company's key product categories in its trade operations include:

It is registered under the Intendencia Lima of the National Superintendency of Customs and Tax Administration (SUNAT) and was recently incorporated into list of major taxpayers. Market Context

For specific business and partnership requests, contacting the company through its official website or LinkedIn profile is recommended. In 2005, the parent group integrated with ,

D&M Pharma was originally founded in May 2003 by a group of Chilean executives with extensive pharmaceutical industry experience. Recognizing the potential for growth in the regional market, the company incorporated —a prestigious Argentine pharmaceutical manufacturer with over 65 years of experience—into its partnership in 2005.

The therapeutic catalog linked to the enterprise spans distinct clinical specialties, heavily leaning toward dermatology, mineral supplementation, and respiratory health. Notable formulations distributed under their local operations listed in Vademecum registers include:

: Tablets and supplements such as Niacider (500 mg) and Recuplus targeted for nutritional and continuous therapeutic care.

is a privately held pharmaceutical enterprise headquartered in Lima, Peru , specializing in the commercialization of respiratory and dermatological products. D&M Pharma Perú S.A.C. Pharmaceutical lab ClosedSan Isidro, Peru Directions Company Overview Key Product Lines and Medical Portfolio If you

At the core of D&M Pharma Peru S.A.C.’s operations is an unwavering commitment to quality. Operating under the rigorous standards set by Peruvian regulatory bodies, including DIGEMID (General Directorate of Medicines, Supplies, and Drugs), the company ensures that every product in its portfolio meets the highest safety and efficacy benchmarks.

The business model of D & M Pharma Peru S.A.C. centers on managing five commercial divisions. Each division targets distinct medical sub-specialties by offering specific, targeted product lines:

Peru has one of the strictest pharmaceutical regulatory bodies in Latin America. For to operate legally, they must possess: